This screening tool can be used by healthcare practitioners to help determine whether an individual may receive a shingles vaccine and to identify the most suitable shingles vaccine to administer based on any pre-existing medical conditions.
There are two licensed shingles vaccines available in the UK. Some individuals who are eligible for vaccination but contraindicated to Zostavax®, due to conditions that result in severe immunosuppression, may be indicated for the non-live shingles vaccine (Shingrix®).
A clinical risk assessment should be undertaken to identify individuals who are severely immunosuppressed and the administration of Shingrix® can then be considered.
If you have an enquiry relating to this publication, please contact email@example.com.
If you have a media enquiry relating to this publication, please contact the Communications and Engagement team.